- €264.38m
- €290.94m
- €62.58m
Brief: Lavipharm FY Net Profit At Eur 1.2 Million
Brief: Lavipharm Will Not Distribute Dividend For 2018
Brief: Lavipharm H1 Net Profit At Eur 0.4 Mln
Brief: Lavipharm Fy 2017 Net Loss Shrinks To Eur 3.7 Mln
Brief: Lavipharm H1 profit after taxes up at 14.37 mln euros
Brief: Lavipharm says Antonis Vogiatzis is now acting as general manager of group
Brief: Lavipharm FY 2015 net loss shrinks to EUR 10.7 million
Brief: Lavipharm repays its US unit non-performing loan
Brief: Lavipharm repays its 2 USA-based units' debt of EUR 27.3 mln
Brief: Lavipharm Q3 net loss widens to EUR 2.7 million
Brief: Lavipharm signs long term agreement with Valeant Group
Brief: Lavipharm Q2 net loss shrinks to 3.2 mln euros
Brief: Lavipharm Q1 net loss widens to 1.45 mln euros
Brief: Lavipharm FY 2014 net loss widens to 28.8 mln euros
Brief: Lavipharm SA 9M turnover at 22.17 mln euros vs 24.51 mln euros yr ago